1
|
Lima Teixeira JF, Henning P, Cintra Magalhães FA, Coletto-Nunes G, Floriano-Marcelino T, Westerlund A, Movérare-Skrtic S, Oliveira GJPL, Lerner UH, Souza PPC. Osteoprotective effect by interleukin-4 (IL-4) on lipoprotein-induced periodontitis. Cytokine 2023; 172:156399. [PMID: 37898012 DOI: 10.1016/j.cyto.2023.156399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 09/15/2023] [Accepted: 10/05/2023] [Indexed: 10/30/2023]
Abstract
Lipoproteins are immunostimulatory bacterial components suggested to participate in inflammation-induced bone loss in periodontal disease through stimulation of osteoclast differentiation. Toll-like receptor 2 activation by Pam2CSK4 (PAM2), known to mimic bacterial lipoproteins, was previously shown to enhance periodontal bone resorption in mice. The anti-inflammatory cytokine interleukin-4 (IL-4) is a known inhibitor of RANKL-induced bone resorption in vitro. Here, we have investigated whether IL-4 could decrease PAM2-induced periodontal bone loss and osteoclastogenesis in vivo. In a model of periodontitis induced by gingival injections of PAM2 in mice, concomitant injections of IL-4 reduced bone loss. Histologically, IL-4 reduced the recruitment of inflammatory cells and the formation of TRAP+ osteoclasts stimulated by PAM2. Mouse bone marrow macrophages (BMMs) and neonatal calvarial osteoblasts were used to assess the effect of IL-4 on PAM2-induced osteoclastogenesis in vitro. In RANKL-primed BMMs stimulated by PAM2 Nfatc1, Ctsk, and Acp5 gene expression was up-regulated and resulted in robust formation of TRAP+ multinucleated osteoclasts, effects which were impaired by IL-4. These effects were mediated by impairment in PAM2-induced c-fos expression. In primary calvarial osteoblast cultures, IL-4 decreased PAM2-induced Tnfsf11 (encoding RANKL) mRNA and enhanced Tnfrsf11b (encoding OPG) expression. Our data demonstrate that the osteoprotective effect by IL-4 on lipoprotein-induced periodontal disease occurs through the inhibition of osteoclastogenesis by three mechanisms, one by acting directly on osteoclast progenitors, another by acting indirectly through decreasing the expression of osteoclast-regulating cytokines in osteoblasts and a third by decreasing inflammation.
Collapse
Affiliation(s)
- Jorge F Lima Teixeira
- Department of Pathology and Physiology, School of Dentistry at Araraquara, Univ. Est. Paulista - UNESP, Araraquara, Brazil
| | - Petra Henning
- Sahlgrenska Osteoporosis Centre and Centre for Bone and Arthritis Research at Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
| | | | - Glaucia Coletto-Nunes
- Department of Pathology and Physiology, School of Dentistry at Araraquara, Univ. Est. Paulista - UNESP, Araraquara, Brazil
| | - Thais Floriano-Marcelino
- Department of Pathology and Physiology, School of Dentistry at Araraquara, Univ. Est. Paulista - UNESP, Araraquara, Brazil
| | - Anna Westerlund
- Sahlgrenska Osteoporosis Centre and Centre for Bone and Arthritis Research at Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
| | - Sofia Movérare-Skrtic
- Sahlgrenska Osteoporosis Centre and Centre for Bone and Arthritis Research at Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
| | - Guilherme J P L Oliveira
- Department of Periodontology and Implantodontology, Dental School, Federal University of Uberlândia - UFU, Uberlândia, Brazil
| | - Ulf H Lerner
- Sahlgrenska Osteoporosis Centre and Centre for Bone and Arthritis Research at Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
| | - Pedro Paulo C Souza
- Innovation in Biomaterials Laboratory (iBioM), Faculty of Dentistry, Federal University of Goiás - UFG, Goiânia, Brazil.
| |
Collapse
|
2
|
Pereira ED, Oliveira LM, Coletto-Nunes G, Souza PPC, Menani JV, De Luca LA, Andrade CAF. Central angiotensinergic mechanisms in female spontaneously hypertensive rats treated with estradiol. Appetite 2022; 174:106012. [PMID: 35367482 DOI: 10.1016/j.appet.2022.106012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Revised: 03/17/2022] [Accepted: 03/18/2022] [Indexed: 11/17/2022]
Abstract
Estrogens reduce 0.3 M NaCl intake and palatability in a widely used model of essential hypertension, the spontaneously hypertensive rats (SHRs). Here we investigated whether the inhibitory effects of β-estradiol (E2, 10 μg/kg b.w. subcutaneously for 8 days) on water deprived partially-rehydrated (WD-PR) ovariectomized (OVX) adult female SHRs (fSHRs, n = 4-10/group) are related to interferences on brain angiotensin II AT1 receptors (AT1r). After WD-PR, E2 reduced 0.3 M NaCl intake (1.3 ± 0.6, vs. vehicle: 3.5 ± 1.2 ml/30 min), the number of hedonic responses to intraoral NaCl infusion (57 ± 11, vs. vehicle: 176 ± 32/min), and the relative angiotensin AT1r (Agtr1a) mRNA expression in the hypothalamus. Losartan (AT1r antagonist, 100 μg) intracerebroventricularly in OVX fSHRs treated with vehicle subcutaneously abolished 0.3 M NaCl intake (0.1 ± 0.1 ml/30 min) and only transiently reduced hedonic responses to intraoral NaCl. Losartan combined with E2 decreased the number of hedonic and increased the number of aversive responses to intraoral NaCl and abolished 0.3 M NaCl intake. E2 also reduced the pressor and dipsogenic responses to intracerebroventricular angiotensin II. The results suggest that AT1r activation increases palatability and induces NaCl intake in WD-PR fSHRs. E2 reduced hypothalamic Agtr1a mRNA expression, which may account for the effects of E2 on NaCl intake and palatability and intracerebroventricular angiotensin II-induced pressor and dipsogenic responses in OVX fSHRs. Future studies considering natural fluctuations in estrogen secretion might help to determine the degree of such interference in brain neuronal activity.
Collapse
Affiliation(s)
- E D Pereira
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil
| | - L M Oliveira
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil
| | - G Coletto-Nunes
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil
| | - P P C Souza
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil
| | - J V Menani
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil
| | - L A De Luca
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil
| | - C A F Andrade
- Department of Physiology and Pathology, School of Dentistry, UNESP, Araraquara, SP, 14801-903, Brazil.
| |
Collapse
|
3
|
Da Ponte Leguizamón N, de Molon RS, Coletto-Nunes G, Nogueira AVB, Rocha SV, Neo-Justino DM, Soares-Costa A, Cerri PS, Lerner UH, Souza PPC, Cirelli JA. Phytocystatin CsinCPI-2 Reduces Osteoclastogenesis and Alveolar Bone Loss. J Dent Res 2021; 101:216-225. [PMID: 34328027 DOI: 10.1177/00220345211027811] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Periodontal disease (PD) is a polymicrobial chronic inflammatory condition of the supporting tissues around the teeth, leading to the destruction of surrounding connective tissue. During the progression of PD, osteoclasts play a crucial role in the resorption of alveolar bone that eventually leads to the loss of teeth if the PD is left untreated. Therefore, the development of antiresorptive therapies targeting bone-resorbing cells will significantly benefit the treatment of PD. Here, we demonstrate the inhibitory effect of CsinCPI-2, a novel cysteine peptidase inhibitor from the orange tree, on periodontitis-induced inflammation, alveolar bone loss, and osteoclast differentiation. Using the ligature-induced periodontitis model in mice, we show that treatment with CsinCPI-2 (0.8 µg/g of body weight) significantly reduced inflammatory cell infiltrate in the connective tissue and prevented the loss of alveolar bone mass (BV/TV) caused by PD, effects associated with diminished numbers of TRAP-positive multinucleated cells. Furthermore, CsinCPI-2 significantly downregulated the numbers of inflammatory cells expressing CD3, CD45, MAC387, and IL-1β. In vitro, CsinCPI-2 inhibited RANKL-induced TRAP+ multinucleated osteoclast formation in mouse bone marrow macrophage cultures in a concentration-dependent manner. This effect was not due to cytotoxicity, as demonstrated by the MTT assay. CsinCPI-2 inhibited RANKL-induced mRNA expression of Acp5, Calcr, and Ctsk, as well as the RANKL-induced upregulation of Nfatc1, a crucial transcription factor for osteoclast differentiation. Based on our findings, CsinCPI-2 prevents bone loss induced by PD by controlling the inflammatory process and acting directly on osteoclastogenesis, suggesting an interesting potential for CsinCPI-2 in the strategy for PD treatment.
Collapse
Affiliation(s)
- N Da Ponte Leguizamón
- Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University-UNESP, Araraquara, Brazil
| | - R S de Molon
- Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University-UNESP, Araraquara, Brazil
| | - G Coletto-Nunes
- Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University-UNESP, Araraquara, Brazil
| | - A V B Nogueira
- Department of Periodontology and Operative Dentistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - S V Rocha
- Department of Genetics and Evolution, Federal University of Sao Carlos, São Carlos, Brazil
| | - D M Neo-Justino
- Department of Genetics and Evolution, Federal University of Sao Carlos, São Carlos, Brazil
| | - A Soares-Costa
- Department of Genetics and Evolution, Federal University of Sao Carlos, São Carlos, Brazil
| | - P S Cerri
- Department of Morphology, Genetics, Orthodontics and Pediatric Dentistry, São Paulo State University-UNESP, Araraquara, Brazil
| | - U H Lerner
- Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - P P C Souza
- Innovation in Biomaterials Laboratory, Faculty of Dentistry, Federal University of Goiás, Goiânia, Brazil
| | - J A Cirelli
- Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University-UNESP, Araraquara, Brazil
| |
Collapse
|